AML Prognosis Improved With Promising Therapy Combinations

HOUSTON—The prognosis for older patients with acute myeloid leukemia (AML) has remained dismal, even after treatment with a hypomethylating agent. Standard curative treatment for AML, which is primarily a disease of older adults with a median age of 68 years at...

Some IBD Patients Have Increased Skin Cancer Risk

Past research has cautioned about the risk of skin cancer with use of immunosuppressive medications. Yet, a new study pointed out, there is limited information on repeated basal cell cancer (BCC) occurrences among inflammatory bowel disease (IBD) patients, especially those who use immunosuppressive medications.